| Literature DB >> 20956541 |
Cristiana Perrotta1, Laura Bizzozero, Denise Cazzato, Sara Morlacchi, Emma Assi, Fabio Simbari, Yang Zhang, Erich Gulbins, Maria Teresa Bassi, Patrizia Rosa, Emilio Clementi.
Abstract
Acid sphingomyelinase (A-SMase) is an important enzyme in sphingolipid metabolism and plays key roles in apoptosis, immunity, development, and cancer. In addition, it mediates cytotoxicity of cisplatin and some other chemotherapeutic drugs. The mechanism of A-SMase activation is still undefined. We now demonstrate that, upon CD95 stimulation, A-SMase is activated through translocation from intracellular compartments to the plasma membrane in an exocytic pathway requiring the t-SNARE protein syntaxin 4. Indeed, down-regulation of syntaxin 4 inhibits A-SMase translocation and activation induced by CD95 stimulation. This leads to inhibition of the CD95-triggered signaling events, including caspase 3 and 9 activation and apoptosis, activation of the survival pathway involving the protein kinase Akt, and important changes in cell cycle and proliferation. The molecular interaction between A-SMase and syntaxin 4 was not known and clarifies the mechanism of A-SMase activation. The novel actions of syntaxin 4 in sphingolipid metabolism and exocytosis we describe here define signaling mechanisms of broad relevance in cell pathophysiology.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20956541 PMCID: PMC3001005 DOI: 10.1074/jbc.M110.139287
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157